Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases

Annals of Surgical Treatment and Research

Volumn 87, Issue 1, 2014, Pages 14-21

  Park, Min Su ^a   Yi, Nam Joon ^a   Son, Sang Yong ^b   You, Tae ^a   Suh, Suk Won ^a   Choi, Young Rok ^a   Kim, Hyeyoung ^a   Hong, Geun ^a   Lee, Kyoung Bun ^a   Lee, Kwang Woong ^a   Jeong, Seung Yong ^a   Park, Kyu Joo ^a   Suh, Kyung Suk ^a   Park, Jae Gahb ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Colorectal neoplasm; Hepatic resection; Inflammation; Liver metastasis; Recurrence

Indexed keywords

EID: 84905023910     PISSN: 22886575     EISSN: 22886796     Source Type: Journal    
DOI: 10.4174/astr.2014.87.1.14     Document Type: Article

References (17)

1. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-Term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-66.
2. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-80.
3. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999; 86: 332-7.
4. Yokoi Y, Suzuki S, Nakamura S. The impact of hepatic resection on metastatic colorectal cancer. Gan To Kagaku Ryoho 2002; 29: 848-55.
5. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-94.
6. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-16.
7. Sorbye H, Mauer M, Gruenberger T, Glimelius B, Poston GJ, Schlag PM, et al. Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg 2012; 255: 534-9.
8. Son SY, Yi NJ, Hong G, Kim H, Park MS, Choi YR, et al. Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy? Korean J Hepatobiliary Pancreat Surg 2011; 15: 206-17.
9. Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR. Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) 2010; 12: 84-93.
10. Shirakusa T, Tsutsui M, Motonaga R, Ando K, Kusano T. Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung. Am Surg 1988; 54: 655-8.
11. Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, et al. Histopathologic prognostic factors in resected colorectal lung metastases. Ann Thorac Surg 2005; 79: 278-82.
12. Nordlinger B, Van Cutsem E, Rougier P, Köhne CH, Ychou M, Sobrero A, et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 2007; 43: 2037-45.
13. Inomata M, Ochiai A, Sugihara K, Moriya Y, Yamaguchi N, Adachi Y, et al. Macroscopic features at the deepest site of tumor penetration predicting liver metastases of colorectal cancer. Jpn J Clin Oncol 1998; 28: 123-8.
14. Ono M, Sakamoto M, Ino Y, Moriya Y, Sugihara K, Muto T, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer 1996; 78: 1179-86.
15. Tominaga K, Nakanishi Y, Nimura S, Yoshimura K, Sakai Y, Shimoda T. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005; 48: 92-100.
16. Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 2006; 45: 246-53.
17. Ding T, Xu J, Wang F, Shi M, Zhang Y, Li SP, et al. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol 2009; 40: 381-9.